Symphony of epigenetic and metabolic regulation—interaction between the histone methyltransferase EZH2 and metabolism of tumor

por Zhang, Tengrui, Gong, Yueqing, Meng, Hui, Li, Chen, Xue, Lixiang
Publicado 2020

Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation

por Wang, Yan, Zhang, Tengrui, Li, Chen, Guo, Jia, Xu, Baohui, Xue, Lixiang
Publicado 2021

Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors

por Li, Chen, Wang, Yan, Gong, Yueqing, Zhang, Tengrui, Huang, Jiaqi, Tan, Zhen, Xue, Lixiang
Publicado 2021

Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor

por Zhang, Tengrui, Guo, Zhengyang, Huo, Xiao, Gong, Yueqing, Li, Chen, Huang, Jiaqi, Wang, Yan, Feng, Hao, Ma, Xiaojuan, Jiang, Changtao, Yin, Qianqian, Xue, Lixiang
Publicado 2022

EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment

por Li, Chen, Song, Jiagui, Guo, Zhengyang, Gong, Yueqing, Zhang, Tengrui, Huang, Jiaqi, Cheng, Rui, Yu, Xiaotong, Li, Yanfang, Chen, Li, Ma, Xiaojuan, Sun, Yan, Wang, Yan, Xue, Lixiang
Publicado 2022